SynthesisCNS oncology2026

Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review.

Dylan Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.